Benitec Biopharma Inc. SEC filings BNTC
Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| DEFA14A | Additional proxy material | Oct 20, 2026 | — |
| DEF 14A | Proxy statement | Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Auditor change
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Auditor change
|
Sep 24, 2026 | Sep 18, 2026 |
| EFFECT | Filing | Sep 21, 2026 | — |
| S-3 | Shelf registration | Sep 14, 2026 | — |
| 10-K | Annual report | Sep 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Officer or director change
|
May 29, 2026 | May 22, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| UPLOAD | Letter from the SEC | Apr 3, 2026 | — |
| CORRESP | Letter to the SEC | Mar 20, 2026 | — |
| 10-K/A | Amended annual report | Mar 20, 2026 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Feb 24, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 10-Q | Quarterly report | Feb 12, 2026 | Dec 31, 2025 |
| 424B3 | Prospectus | Feb 11, 2026 | — |
| EFFECT | Filing | Feb 10, 2026 | — |
| CORRESP | Letter to the SEC | Feb 6, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 2, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Nov 12, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 7, 2025 | Nov 5, 2025 |
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Nov 5, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Nov 3, 2025 | Nov 2, 2025 |
| DEFA14A | Additional proxy material | Oct 14, 2025 | — |
| DEF 14A | Proxy statement | Oct 14, 2025 | Dec 1, 2025 |
| EFFECT | Filing | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2025 | — |
| S-3 | Shelf registration | Sep 22, 2025 | — |
| 8-K |
Current report
Results of operations
|
Sep 22, 2025 | Sep 22, 2025 |
| 10-K | Annual report | Sep 22, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Restatement
|
Sep 12, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| EFFECT | Filing | Jun 2, 2025 | — |
| 424B3 | Prospectus | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | May 29, 2025 | — |
| UPLOAD | Letter from the SEC | May 29, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2025 | Mar 26, 2025 |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 26, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 31, 2024 | Dec 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 6, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| DEFA14A | Additional proxy material | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2024 | Nov 7, 2024 |
| EFFECT | Filing | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| S-3 | Shelf registration | Nov 1, 2024 | — |
| DEF 14A | Proxy statement | Oct 22, 2024 | Dec 4, 2024 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 12, 2024 |
| 424B5 | Prospectus supplement | Oct 15, 2024 | — |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 8, 2024 |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| 8-K |
Current report
Results of operations
|
Sep 26, 2024 | Sep 26, 2024 |
| 10-K | Annual report | Sep 26, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 5, 2024 | Aug 29, 2024 |
| DEF 14A | Proxy statement | Jul 29, 2024 | Aug 29, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 26, 2024 |
| 424B3 | Prospectus | May 29, 2024 | — |
| EFFECT | Filing | May 28, 2024 | — |
| CORRESP | Letter to the SEC | May 23, 2024 | — |
| UPLOAD | Letter from the SEC | May 22, 2024 | — |
| S-1 | Registration statement | May 16, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| D | Filing | Apr 25, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 19, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2024 | Mar 6, 2024 |
| EFFECT | Filing | Mar 5, 2024 | — |
| CORRESP | Letter to the SEC | Mar 1, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2024 | — |
| DEL AM | Filing | Feb 26, 2024 | — |
| S-3 | Shelf registration | Feb 23, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| 10-Q | Quarterly report | Feb 13, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Dec 26, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 7, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Oct 20, 2023 | — |
| DEF 14A | Proxy statement | Oct 20, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Other events
|
Sep 28, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Results of operations
|
Sep 21, 2023 | Sep 21, 2023 |
| 10-K | Annual report | Sep 21, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 18, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 11, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 10, 2023 | Aug 9, 2023 |
| 424B4 | Prospectus | Aug 10, 2023 | — |
| EFFECT | Filing | Aug 8, 2023 | — |
| S-1/A | Amended registration statement | Aug 7, 2023 | — |
| CORRESP | Letter to the SEC | Aug 3, 2023 | — |
| CORRESP | Letter to the SEC | Aug 3, 2023 | — |
| S-1/A | Amended registration statement | Aug 3, 2023 | — |
| S-1/A | Amended registration statement | Jul 31, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 25, 2023 | Jul 25, 2023 |
| UPLOAD | Letter from the SEC | Jul 11, 2023 | — |
| S-1 | Registration statement | Jul 7, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 8, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2023 | Feb 13, 2023 |
| 10-Q | Quarterly report | Feb 13, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| EFFECT | Filing | Dec 19, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2022 | — |
| S-1 | Registration statement | Dec 13, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 12, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 8, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEF 14A | Proxy statement | Oct 25, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2022 | Oct 12, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 14, 2022 | Oct 14, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2022 | Sep 12, 2022 |
| 424B4 | Prospectus | Sep 14, 2022 | — |
| EFFECT | Filing | Sep 12, 2022 | — |
| S-1/A | Amended registration statement | Sep 12, 2022 | — |
| S-1/A | Amended registration statement | Sep 9, 2022 | — |
| CORRESP | Letter to the SEC | Sep 8, 2022 | — |
| CORRESP | Letter to the SEC | Sep 8, 2022 | — |
| 8-K |
Current report
Listing notice
|
Sep 7, 2022 | Sep 6, 2022 |
| 10-K | Annual report | Sep 2, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Sep 2, 2022 | Sep 2, 2022 |
| CORRESP | Letter to the SEC | Aug 11, 2022 | — |
| S-1/A | Amended registration statement | Aug 10, 2022 | — |
| CORRESP | Letter to the SEC | Aug 8, 2022 | — |
| CORRESP | Letter to the SEC | Aug 8, 2022 | — |
| S-1/A | Amended registration statement | Aug 8, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2022 | — |
| S-1 | Registration statement | Jul 29, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 10-Q | Quarterly report | Feb 14, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2022 | Feb 14, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jan 21, 2022 | Dec 8, 2021 |
| S-8 | Employee stock plan registration | Dec 23, 2021 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 21, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 13, 2021 | Dec 8, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| DEF 14A | Proxy statement | Oct 22, 2021 | Dec 8, 2021 |
| PRE 14A | Preliminary proxy statement | Oct 12, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 20, 2021 | Sep 20, 2021 |
| 10-K | Annual report | Sep 20, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 29, 2021 | Apr 27, 2021 |
| 424B5 | Prospectus supplement | Apr 29, 2021 | — |
| FWP | Free writing prospectus | Apr 28, 2021 | — |
| FWP | Free writing prospectus | Apr 27, 2021 | — |
| 424B5 | Prospectus supplement | Apr 27, 2021 | — |
| EFFECT | Filing | Feb 26, 2021 | — |
| CORRESP | Letter to the SEC | Feb 25, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 24, 2021 | Feb 24, 2021 |
| UPLOAD | Letter from the SEC | Feb 24, 2021 | — |
| S-3 | Shelf registration | Feb 18, 2021 | — |
| S-8 | Employee stock plan registration | Feb 18, 2021 | — |
| 10-Q | Quarterly report | Feb 9, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2020 | Dec 9, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 14, 2020 | Dec 9, 2020 |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Auditor change
|
Nov 3, 2020 | Nov 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2020 | Oct 22, 2020 |
| DEF 14A | Proxy statement | Oct 22, 2020 | Dec 9, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 6, 2020 | Oct 2, 2020 |
| 424B4 | Prospectus | Oct 6, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BNTC (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1808898
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.